Zhenbo Tu

906 total citations
22 papers, 520 citations indexed

About

Zhenbo Tu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhenbo Tu has authored 22 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Zhenbo Tu's work include Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (4 papers) and RNA modifications and cancer (4 papers). Zhenbo Tu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (4 papers) and RNA modifications and cancer (4 papers). Zhenbo Tu collaborates with scholars based in China, United States and Singapore. Zhenbo Tu's co-authors include Qiuping Zhang, Antoine E. Karnoub, Jie Xiong, Xinzhou Deng, R. Xiao, Meng Xiong, Bingjiao Yin, Benjamin Cuiffo, Shan Pan and Xiaoxing Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Molecular Cell.

In The Last Decade

Zhenbo Tu

21 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenbo Tu China	14	328	237	158	106	82	22	520
Zhuqing Zhou China	14	329 1.0×	205 0.9×	150 0.9×	66 0.6×	97 1.2×	26	529
Sylvia Mahara Singapore	8	502 1.5×	179 0.8×	210 1.3×	80 0.8×	47 0.6×	9	658
Zhihong Ai China	12	427 1.3×	275 1.2×	117 0.7×	88 0.8×	53 0.6×	23	648
Ori Hassin Israel	6	307 0.9×	136 0.6×	264 1.7×	65 0.6×	75 0.9×	8	522
Silei Sui China	11	248 0.8×	131 0.6×	192 1.2×	110 1.0×	134 1.6×	13	474
Melissa M. Wolf United States	7	502 1.5×	306 1.3×	228 1.4×	103 1.0×	128 1.6×	13	720
Ailan Cheng China	12	361 1.1×	134 0.6×	128 0.8×	81 0.8×	51 0.6×	28	493
Raoying Xie China	13	442 1.3×	387 1.6×	139 0.9×	115 1.1×	40 0.5×	21	685
Adeleye O. Adeshakin China	9	267 0.8×	164 0.7×	219 1.4×	254 2.4×	83 1.0×	19	552
Meng-Xuan Zhu China	10	398 1.2×	235 1.0×	156 1.0×	128 1.2×	83 1.0×	15	582

Countries citing papers authored by Zhenbo Tu

Since Specialization

Citations

This map shows the geographic impact of Zhenbo Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenbo Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenbo Tu more than expected).

Fields of papers citing papers by Zhenbo Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenbo Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenbo Tu. The network helps show where Zhenbo Tu may publish in the future.

Co-authorship network of co-authors of Zhenbo Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenbo Tu. A scholar is included among the top collaborators of Zhenbo Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenbo Tu. Zhenbo Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tu, Zhenbo, Mahmoud A. Bassal, George W. Bell, et al.. (2024). Tumor-suppressive activities for pogo transposable element derived with KRAB domain via ribosome biogenesis restriction. Molecular Cell. 84(21). 4209–4223.e6. 3 indexed citations

Huang, Daoyuan, Zhenbo Tu, Antoine E. Karnoub, Wenyi Wei, & Abdol-Hossein Rezaeian. (2024). Busulfan Chemotherapy Downregulates TAF7/TNF-α Signaling in Male Germ Cell Dysfunction. Biomedicines. 12(10). 2220–2220.

Bin, Xiaoyun, Yu Luo, Peng Huang, et al.. (2023). The Role of H2-Calponin Antigen in Cancer Metastasis: Presence of Autoantibodies in Liver Cancer Patients. International Journal of Molecular Sciences. 24(12). 9864–9864. 1 indexed citations

Tu, Zhenbo & Antoine E. Karnoub. (2022). Mesenchymal stem/stromal cells in breast cancer development and management. Seminars in Cancer Biology. 86(Pt 2). 81–92. 27 indexed citations

Tu, Zhenbo, Shengqi Hou, Yurong Zheng, et al.. (2021). In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization. iScience. 24(5). 102425–102425. 4 indexed citations

Dang, Fabin, Li Nie, Jin Zhou, et al.. (2021). Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer. Nature Communications. 12(1). 5386–5386. 33 indexed citations

Tu, Zhenbo, Johannes Schmoellerl, Odette Mariani, et al.. (2021). The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer. npj Breast Cancer. 7(1). 69–69. 12 indexed citations

Sun, Jiaxing, Tian Xie, Muhammad Jamal, et al.. (2020). CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment. Cancer Cell International. 20(1). 106–106. 38 indexed citations

Tu, Zhenbo, et al.. (2020). UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 24(14). 8069–8077. 14 indexed citations

10.

Tu, Zhenbo, et al.. (2019). Microenvironmental Regulation of Long Noncoding RNA LINC01133 Promotes Cancer Stem Cell-Like Phenotypic Traits in Triple-Negative Breast Cancers. Stem Cells. 37(10). 1281–1292. 42 indexed citations

11.

Tu, Zhenbo, Jie Xiong, R. Xiao, et al.. (2018). Loss of miR‐146b‐5p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL‐17A pathway. Journal of Cellular Biochemistry. 120(4). 5936–5948. 19 indexed citations

12.

Hao, Ling, R. Xiao, Xinran Li, et al.. (2017). Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer. Oncology Letters. 13(4). 2670–2678. 10 indexed citations

13.

Huang, Xiaoxing, R. Xiao, Shan Pan, et al.. (2017). Uncovering the roles of long non-coding RNAs in cancer stem cells. Journal of Hematology & Oncology. 10(1). 62 indexed citations

14.

Deng, Xinzhou, Zhenbo Tu, Meng Xiong, et al.. (2017). Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis. Oncotarget. 8(24). 39033–39047. 28 indexed citations

15.

Tu, Zhenbo, Songping Xie, Meng Xiong, et al.. (2016). CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. International Journal of Oncology. 50(2). 505–514. 32 indexed citations

16.

Huang, Xiaoxing, Meng Xiong, Chaohua Deng, et al.. (2016). Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties. International Journal of Oncology. 49(1). 343–351. 7 indexed citations

17.

Tu, Zhenbo, Du He, Xinzhou Deng, et al.. (2016). An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer. Oncology Reports. 36(1). 215–222. 24 indexed citations

18.

Xie, Songping, Zhenbo Tu, Jie Xiong, et al.. (2016). CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Oncology Reports. 37(2). 921–928. 27 indexed citations

19.

Tu, Zhenbo, R. Xiao, Jie Xiong, et al.. (2016). CCR9 in cancer: oncogenic role and therapeutic targeting. Journal of Hematology & Oncology. 9(1). 10–10. 72 indexed citations

20.

Tu, Zhenbo, et al.. (2016). The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. Oncotarget. 7(15). 20507–20519. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact